Third Rock Ventures Iii, L.P. Fulcrum Therapeutics, Inc. (FULC) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 1.96 Million shares of FULC, which is worth approximately $6.2 Million. The most recent transaction as insider was on Dec 13, 2022, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.96M

0% 3M change

0% 12M change

Total Value Held $6.2 Million

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 13 2022	SELL Other acquisition or disposition	-	2,000,000 Reduced 50.48%	1,962,202 Common Stock
Nov 10 2021	SELL Other acquisition or disposition	-	1,000,000 Reduced 20.15%	3,962,202 Common Stock
Sep 22 2021	SELL Other acquisition or disposition	-	1,000,000 Reduced 16.77%	4,962,202 Common Stock
Jul 22 2019	BUY Open market or private purchase	$1,300,000 $16.0 p/Share	81,250 Added 1.34%	5,962,202 Common Stock
Jul 22 2019	BUY Conversion of derivative security	-	5,595,238 Added 48.76%	5,880,952 Common Stock

Also insider at

RLAY

Relay Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

NRIX

Nurix Therapeutics, Inc. Healthcare

> 10% Shareholder

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

> 10% Shareholder

VYGR

Voyager Therapeutics, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

MYOK

MyoKardia Inc

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

TRV